Skip to main content

Table 3 Expression of three selected miRNA among different AML subgroup

From: Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia

 

miR-181a-2

P *

miR-25

P *

miR-362

P *

Risk category a

 Favorable

11.58 ± 0.71

0.046

15.08 ± 0.55

0.004

3.32 ± 1.22

0.001

 Intermediate

10.78 ± 1.54

14.55 ± 0.66

4.36 ± 1.09

 Poor

11.15 ± 0.98

14.59 ± 0.54

4.29 ± 0.96

FAB morphologyb

M0 Undifferentiated

11.94 ± 0.73

< 0.001

14.95 ± 0.41

0.079

3.88 ± 1.11

< 0.001

 M1

11.12 ± 1.32

14.61 ± 0.61

3.88 ± 1.15

 M2

11.34 ± 1.13

14.77 ± 0.60

3.52 ± 1.07

 M4

10.66 ± 1.17

14.54 ± 0.65

4.73 ± 1.02

 M5

9.70 ± 1.99

14.27 ± 0.70

5.02 ± 0.77

 M6

11.57 ± 1.07

14.67 ± 1.18

5.25 ± 0.04

 M7

10.93 ± 1.09

14.57 ± 1.00

4.53 ± 0.35

  1. aRisk information of two cases were missing in the TCGA data
  2. bFAB morphology information of one living patient was missing